Breast Cancer Drugs
-
{
- All
- News
-
'Smart' Cancer Drug To Target Tumour Cells, Spare Healthy Ones: May Change Cancer Treatment
- Tuesday September 1, 2026
- Health | Reported by Tanushka Dutta
A new smart cancer drug targets tumour cells while sparing healthy ones, offering hope for safer and more effective cancer treatment.
-
www.ndtv.com/health
-
Drug Combo Cuts Breast Cancer Deaths In Key Trial
- Thursday March 2, 2017
- Health | Reuters
Combining Roche's Perjeta and Herceptin drugs with chemotherapy reduced recurrence of aggressive breast cancer or death compared to Herceptin and chemo, the Swiss drugmaker said on Thursday.
-
www.ndtv.com/health
-
Drug Combo Cuts Breast Cancer Deaths In Key Trial
- Thursday March 2, 2017
- Health | Reuters
Combining Roche's Perjeta and Herceptin drugs with chemotherapy reduced recurrence of aggressive breast cancer or death compared to Herceptin and chemo, the Swiss drugmaker said on Thursday.
-
www.ndtv.com/health
-
Glenmark, US-Based Particle Sciences To Develop Generic Cancer Drug
- Monday September 19, 2016
- Press Trust of India
Glenmark Pharmaceuticals on Monday said it has entered into an agreement with US-based Particle Sciences Inc to develop and market a generic version of Celgene's ABRAXANE, which is used in treatments of breast and lung cancers.
-
www.ndtvprofit.com
-
European Advisory Panel Recommends Nod For Pfizer Breast Cancer Drug
- Friday September 16, 2016
- Reuters
US drug maker Pfizer Inc's breast cancer drug, Ibrance, should be given marketing approval, an advisory committee at the European Medicines Agency recommended.
-
www.ndtvprofit.com
-
Breast Cancer Drug Also Highly Potent Against Leukaemia
- Wednesday May 18, 2016
- Indo-Asian News Service
The compound from breast cancer therapy deprives the cancer cells of "nutrients". AML cancer cells carrying the mutation died immediately in the experiments.
-
everylifecounts.ndtv.com
-
Court Allows Biocon, Mylan To Continue To Manufacture Cancer Drugs
- Tuesday April 26, 2016
- Press Trust of India
The Delhi High Court has allowed pharmaceutical firms Biocon Ltd and Mylan Pharmaceuticals Pvt Ltd to continue manufacturing and marketing their breast cancer drug under brand names CANMAb and HERTRAZ.
-
www.ndtvprofit.com
-
Breast Cancer Drug May Protect Against Killer Superbugs: Study
- Wednesday October 14, 2015
- Health | Press Trust of India
A common breast cancer drug could wipe out an antibiotic-resistant notorious superbug responsible for several difficult-to-treat infections in different parts of the body, according to a new research.
-
www.ndtv.com/health
-
Breast Cancer Drug May Protect Against Killer Superbugs: Study
- Wednesday October 14, 2015
- Health | Press Trust of India
A common breast cancer drug could wipe out an antibiotic-resistant notorious superbug responsible for several difficult-to-treat infections in different parts of the body, according to a new research.
-
www.ndtv.com/health
-
'Smart' Cancer Drug To Target Tumour Cells, Spare Healthy Ones: May Change Cancer Treatment
- Tuesday September 1, 2026
- Health | Reported by Tanushka Dutta
A new smart cancer drug targets tumour cells while sparing healthy ones, offering hope for safer and more effective cancer treatment.
-
www.ndtv.com/health
-
Drug Combo Cuts Breast Cancer Deaths In Key Trial
- Thursday March 2, 2017
- Health | Reuters
Combining Roche's Perjeta and Herceptin drugs with chemotherapy reduced recurrence of aggressive breast cancer or death compared to Herceptin and chemo, the Swiss drugmaker said on Thursday.
-
www.ndtv.com/health
-
Drug Combo Cuts Breast Cancer Deaths In Key Trial
- Thursday March 2, 2017
- Health | Reuters
Combining Roche's Perjeta and Herceptin drugs with chemotherapy reduced recurrence of aggressive breast cancer or death compared to Herceptin and chemo, the Swiss drugmaker said on Thursday.
-
www.ndtv.com/health
-
Glenmark, US-Based Particle Sciences To Develop Generic Cancer Drug
- Monday September 19, 2016
- Press Trust of India
Glenmark Pharmaceuticals on Monday said it has entered into an agreement with US-based Particle Sciences Inc to develop and market a generic version of Celgene's ABRAXANE, which is used in treatments of breast and lung cancers.
-
www.ndtvprofit.com
-
European Advisory Panel Recommends Nod For Pfizer Breast Cancer Drug
- Friday September 16, 2016
- Reuters
US drug maker Pfizer Inc's breast cancer drug, Ibrance, should be given marketing approval, an advisory committee at the European Medicines Agency recommended.
-
www.ndtvprofit.com
-
Breast Cancer Drug Also Highly Potent Against Leukaemia
- Wednesday May 18, 2016
- Indo-Asian News Service
The compound from breast cancer therapy deprives the cancer cells of "nutrients". AML cancer cells carrying the mutation died immediately in the experiments.
-
everylifecounts.ndtv.com
-
Court Allows Biocon, Mylan To Continue To Manufacture Cancer Drugs
- Tuesday April 26, 2016
- Press Trust of India
The Delhi High Court has allowed pharmaceutical firms Biocon Ltd and Mylan Pharmaceuticals Pvt Ltd to continue manufacturing and marketing their breast cancer drug under brand names CANMAb and HERTRAZ.
-
www.ndtvprofit.com
-
Breast Cancer Drug May Protect Against Killer Superbugs: Study
- Wednesday October 14, 2015
- Health | Press Trust of India
A common breast cancer drug could wipe out an antibiotic-resistant notorious superbug responsible for several difficult-to-treat infections in different parts of the body, according to a new research.
-
www.ndtv.com/health
-
Breast Cancer Drug May Protect Against Killer Superbugs: Study
- Wednesday October 14, 2015
- Health | Press Trust of India
A common breast cancer drug could wipe out an antibiotic-resistant notorious superbug responsible for several difficult-to-treat infections in different parts of the body, according to a new research.
-
www.ndtv.com/health